Evaluation of the usefullness of perioperative administration of tiotropium and indacaterol in lung cancer patients with COPD.

Not Applicable

• Conditions: Chronic obstructive pulmonary disease

• Registration Number: JPRN-UMIN000010948
• Lead Sponsor: Mie University Graduate School of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-06-13
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with large atelectasis. 2) Patients with clear evidence of underlying bronchial asthma. 3) Patients that had airway infection or COPD exacerbation within the past 3 months after administration of the drug on trial. 4) Patients that cannot stop smoking at the start of the study. 5) Patients with a history of hypersensitivity to Tiotropium or Indacaterol. 6) Patients with benign prostatic hyperplasia. 7) Patients with glaucoma. 8) Pregnant or breast feeding patients. 9) Patients considered as ineligible by the panel of investigators.

Study & Design

• Study Type: Interventional
• Study Design: Not specified